Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-029971
Filing Date
2025-06-06
Accepted
2025-06-06 16:04:18
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749240252.html 4  
1 FORM 4 wk-form4_1749240252.xml 4 3472
  Complete submission text file 0001628280-25-029971.txt   4882
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Skovronsky Daniel (Reporting) CIK: 0001741474 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 251030501